Alzamend Neuro
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alzamend Neuro and other ETFs, options, and stocks.About ALZN
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which is in Phase II clinical trial, and delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bipolar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders, and AL002, which completed preclinical stage, and uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease.
ALZN Key Statistics
Stock Snapshot
Alzamend Neuro(ALZN) stock is priced at $1.33, giving the company a market capitalization of 6.44M. It carries a P/E multiple of -0.46.
On 2026-07-25, Alzamend Neuro(ALZN) stock traded between a low of $1.23 and a high of $1.36. Shares are currently priced at $1.33, which is +8.1% above the low and -2.2% below the high.
Alzamend Neuro(ALZN) shares are trading with a volume of 48.9K, against a daily average of 60.96K.
During the past year, Alzamend Neuro(ALZN) stock moved between $0.84 at its lowest and $3.01 at its peak.
During the past year, Alzamend Neuro(ALZN) stock moved between $0.84 at its lowest and $3.01 at its peak.
ALZN News
...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.